Microsoft Word - CHO_MORCENX_EN_27-07-2015.docx Press release Bordeaux, 27 July 2015



CHO Morcenx : update on « Final Acceptance with reserves » (FAR)

Initial test results prove 10MW+ electrical generation capacity

Following a transformer failure, the FAR protocol is temporary suspended and will resume in September.

The first series of tests, executed in June, were satisfactory:
The CHO Morcenx plant was operated for 15 days, during which it has demonstrated its capacity to reach maximum performance levels on key operating parameters: waste/biomass injection > 8t/h, turbine production
> 6MWe, syngas LHV > 6MJ/kg, etc.
A particularly important milestone has also been reached, as the plant was capable of generating a quantity of energy in the syngas significantly exceeding the minimum required to generate 10MWe of renewable electricity once all the engines are installed.
However, an incident on an auxiliary equipment (an electrical transformer coupled to the rectifier) has forced CHO Power to stop the plant temporarily. A full root-cause analysis is being conducted with the supplier, and the manufacturer is mobilizing resources in August to accelerate the repair.
As a result, execution of the last tests required to complete the FAR protocol is expected to resume in
September.
This incident is all the more regrettable as it does not relate to the CHO Power process or technology. All measures are being taken to mitigate or neutralize the cash impact of this delay.
Given the strong performance to-date, key next milestones include the rapid resumption of the FAR protocol, and the continuation of the pipeline development, with a particular focus on securing the final authorizations for CHO Tiper.

About EUROPLASMA

At the heart of environmental issues, EUROPLASMA designs and develops innovative plasma solutions for renewable energy generation and hazardous waste recovery, as well as related applications for multi-sector companies wishing to reduce their environmental footprint.
EUROPLASMA is listed on Alternext (FR0000044810-ALEUP). For more information:
www.europlasam.com

Press and investor contacts

Anne Bordères - Communication Manager Tel: + 33 (0) 556 497 000 contactbourse@europlasma.com
distributed by